Maze's Mission & Approach

We are focused on harnessing the power of human genetics to transform the lives of patients

Dramatic advances in human genetics, therapeutic discovery and development methods now enable us to decode the mysteries of the genetic drivers behind a wide range of serious diseases

Maze is building a broad portfolio of wholly owned and partnered programs. Focusing on genetically informed therapies for common diseases such as chronic kidney disease. Maze’s Compass Platform™ enables variant functionalization in tandem, with advanced data science methods, and a robust suite of research and development capabilities to advance a pipeline of novel precision medicines.